stars 1 stars 2 stars 3

INOFEA empowers enzymes. Enzyme stabilization and protection is INOFEA`s core business. We have developed an innovative and patented platform technology to provide enzymes with a protective shield. We unlock the full potential value of enzymes, providing a seamless level of enhanced properties, unlike any other existing technology. This makes your enzymes 10 times more stable and they can be re-used easily. Our highly resistant enzymes support Biocatalysis including bioconjugation, diagnostics (bioanalysis) or can be formulated as active ingredients. Our technology addresses a wide range of biotech applications for the industry and demonstrated substantial benefits to customers in pharma, food processing, specialty chemicals and consumer care.

INOFEA AG Questions

The INOFEA AG annual revenue was $1 million in 2026.

Christoph Becker is the CEO of INOFEA AG.

9 people are employed at INOFEA AG.

INOFEA AG is based in Basel, Basel-City.

The NAICS codes for INOFEA AG are [54171, 541, 541713, 54, 5417].

The SIC codes for INOFEA AG are [873, 87].

Top INOFEA AG Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users